The underlying physiological and cellular disease state characterized by a cluster of interconnected metabolic risk factors, including central obesity, elevated blood pressure, dyslipidemia, and impaired fasting glucose or insulin resistance. This pathology represents a state of chronic energy imbalance and systemic low-grade inflammation that significantly increases the risk for cardiovascular disease and type 2 diabetes. It is a critical health challenge of modern society.
Origin
The term “Metabolic Syndrome” was formally recognized in the late 20th century to categorize the co-occurrence of these specific risk factors, realizing they shared a common underlying pathology, primarily insulin resistance. The addition of ‘Pathology’ emphasizes the cellular and molecular disease process rather than just the clinical diagnostic criteria. This recognition was a paradigm shift in understanding chronic disease.
Mechanism
The core mechanism is visceral adiposity leading to insulin resistance and a pro-inflammatory state. Adipose tissue dysfunction results in the excessive release of free fatty acids and pro-inflammatory adipokines, which impair insulin signaling in the liver and muscle. This cycle leads to increased hepatic glucose production, reduced peripheral glucose uptake, and dyslipidemia, driving the full spectrum of the syndrome’s clinical manifestations.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.